| Natural History of MYH7-Related Dilated Cardiomyopathy F De Frutos, JP Ochoa, M Navarro-Peñalver, A Baas, JV Bjerre, E Zorio, ... Journal of the American College of Cardiology 80 (15), 1447-1461, 2022 | 35 | 2022 |
| UNRAVEL: big data analytics research data platform to improve care of patients with cardiomyopathies using routine electronic health records and standardised biobanking A Sammani, M Jansen, M Linschoten, A Bagheri, N de Jonge, H Kirkels, ... Netherlands Heart Journal 27, 426-434, 2019 | 29 | 2019 |
| Multi-omics integration identifies key upstream regulators of pathomechanisms in hypertrophic cardiomyopathy due to truncating MYBPC3 mutations J Pei, M Schuldt, E Nagyova, Z Gu, S El Bouhaddani, L Yiangou, ... Clinical epigenetics 13, 1-20, 2021 | 25 | 2021 |
| Mitochondrial dysfunction in human hypertrophic cardiomyopathy is linked to cardiomyocyte architecture disruption and corrected by improving NADH-driven mitochondrial respiration EE Nollet, I Duursma, A Rozenbaum, M Eggelbusch, RCI Wüst, ... European heart journal 44 (13), 1170-1185, 2023 | 17 | 2023 |
| Automatic identification of patients with unexplained left ventricular hypertrophy in electronic health record data to improve targeted treatment and family screening A Sammani, M Jansen, NM de Vries, N de Jonge, AF Baas, ... Frontiers in cardiovascular medicine 9, 768847, 2022 | 8 | 2022 |
| Blood‐based biomarkers for the prediction of hypertrophic cardiomyopathy prognosis: a systematic review and meta‐analysis M Jansen, S Algül, LP Bosman, M Michels, J van der Velden, RA De Boer, ... ESC heart failure 9 (5), 3418-3434, 2022 | 7 | 2022 |
| BIO FOr CARE: biomarkers of hypertrophic cardiomyopathy development and progression in carriers of Dutch founder truncating MYBPC3 variants—design and … M Jansen, I Christiaans, SN van der Crabben, M Michels, R Huurman, ... Netherlands Heart Journal 29, 318-329, 2021 | 7 | 2021 |
| Mortality risk associated with truncating founder mutations in titin M Jansen, AF Baas, KY van Spaendonck-Zwarts, AS Ummels, ... Circulation: Genomic and Precision Medicine 12 (5), e002436, 2019 | 7 | 2019 |
| Distinct metabolomic signatures in preclinical and obstructive hypertrophic cardiomyopathy M Schuldt, B van Driel, S Algül, RY Parbhudayal, ... Cells 10 (11), 2950, 2021 | 6 | 2021 |
| Untargeted Metabolomics Identifies Potential Hypertrophic Cardiomyopathy Biomarkers in Carriers of MYBPC3 Founder Variants M Jansen, M Schuldt, BO van Driel, AF Schmidt, I Christiaans, ... International journal of molecular sciences 24 (4), 4031, 2023 | 3 | 2023 |
| Penetrance and Prognosis of MYH7 Variant-Associated Cardiomyopathies: Results From a Dutch Multicenter Cohort Study M Jansen, R de Brouwer, F Hassanzada, AE Schoemaker, AF Schmidt, ... Heart Failure 12 (1), 134-147, 2024 | 2 | 2024 |
| Circulating Acylcarnitines Associated with Hypertrophic Cardiomyopathy Severity: an Exploratory Cross-Sectional Study in MYBPC3 Founder Variant Carriers M Jansen, AF Schmidt, JJM Jans, I Christiaans, SN van der Crabben, ... Journal of cardiovascular translational research 16 (6), 1267-1275, 2023 | 1 | 2023 |
| Strength of patient cohorts and biobanks for cardiomyopathy research RA de Boer, L Nijenkamp, HHW Silljé, TR Eijgenraam, R Parbhudayal, ... Netherlands Heart Journal 28, 50-56, 2020 | 1 | 2020 |
| Recreational and occupational physical activity and risk of adverse events in truncating MYBPC3 founder variant carriers F Hassanzada, M Jansen, FHM van Lint, LP Bosman, AF Schmidt, ... medRxiv, 2024.01. 10.24301022, 2024 | | 2024 |
| Novel Frontiers in Sarcomeric Cardiomyopathies: Biomarkers, Early Detection and Prognosis M Jansen Utrecht University, 2023 | | 2023 |
| Multi-omics integration delineates the key regulators and pathomechanisms in hypertrophic cardiomyopathy due to truncating MYBPC3 mutations J Pei, M Schuldt, E Nagyova, Z Gu, S el Bouhaddani, M Jansen, JJA Calis, ... Multi-omics dissection of acquired and inherited heart failure, 101, 2020 | | 2020 |
| 337 Value of feature tracking cardiovascular magnetic resonance imaging in detecting genotype-positive hypertrophic cardiomyopathy GJ Erkelens, M Bourfiss, M Jansen, AF Baas, FW Asselbergs, BK Velthuis European Heart Journal-Cardiovascular Imaging 20 (Supplement_2), jez122. 006, 2019 | | 2019 |
| Streptococcus milleri-endocarditis met secundaire hersenabcessen LS Patrick van der Geest, Naomi Overgaauw, Mark Jansen Tijdschrift voor infectieziekten 12 (6), 203-208, 2017 | | 2017 |
| Unravel iDCM Registry: unravelling aetiologies of seemingly idiopathic dilated cardiomyopathy. A Sammani, MPM Linschoten, M Jansen, EPA van Iperen, JP van Tintelen, ... European journal of clinical investigation 46 (Suppl. 1), 2016 | | 2016 |
